Apixaban in Patients With Sickle Cell Disease

Summary

In patients with SCD, the use of low dose anticoagulation as an outpatient may lead to a significant decrease in morbidity and as a result, decrease healthcare utilization and costs. This study attempts to critically avoid admissions by reducing daily pain scores and pain crisis as an outpatient by use of a novel oral anticoagulant.

Timeline

Start

2015-01

Primary completion

2017-09-03

Completion

2017-09-03

Drugs

Indications